Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer

BACKGROUND: Microorganisms that can be used for their lytic activity against tumor cells as well as inducing or reactivating antitumor immune responses are a relevant part of the available immunotherapy strategies. Viruses, bacteria and even protozoa have been largely explored with success as effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lantier, Louis, Poupée-Beaugé, Agathe, di Tommaso, Anne, Ducournau, Céline, Epardaud, Mathieu, Lakhrif, Zineb, Germon, Stéphanie, Debierre-Grockiego, Françoise, Mévélec, Marie-Noëlle, Battistoni, Arthur, Coënon, Loïs, Deluce-Kakwata-Nkor, Nora, Velge-Roussel, Florence, Beauvillain, Céline, Baranek, Thomas, Lee, Gordon Scott, Kervarrec, Thibault, Touzé, Antoine, Moiré, Nathalie, Dimier-Poisson, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705568/
https://www.ncbi.nlm.nih.gov/pubmed/33257408
http://dx.doi.org/10.1136/jitc-2020-001242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705568/
https://www.ncbi.nlm.nih.gov/pubmed/33257408
http://dx.doi.org/10.1136/jitc-2020-001242

Ejemplares similares